Status:
COMPLETED
Iron and COVID-19 Vaccine Response
Lead Sponsor:
Jomo Kenyatta University of Agriculture and Technology
Conditions:
Iron Deficiency Anemia
Vaccine Response Impaired
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
Vaccines often underperform in Africa compared to high-income countries. Why vaccines do not work as well in Africa remains uncertain. Malnutrition likely plays a role. Our study objective is to asses...
Detailed Description
Group 1 (immediate iron treatment) will receive iron treatment before vaccination. Women in both groups will receive the 1st dose of the COVID-19 vaccine. Vaccine response will be measured 28 and 56 d...
Eligibility Criteria
Inclusion
- 18-55 years old Zinc protoporphyrin \> or equal 40 mmol/mol heme hemoglobin \< or equal 109 g/L no malaria no known HIV infection no medical condition that precludes study involvement no iron supplementation 1 week prior to study start no recent tuberculosis infection no vaccination of yellow fever or influenza prior to enrolment not pregnant
Exclusion
- \-
Key Trial Info
Start Date :
May 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2021
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT04915820
Start Date
May 29 2021
End Date
September 9 2021
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Msambweni County Referral Hospital
Msambweni, Kwale County, Kenya